Chad C. MacArthur1, Andrew Fontes1, Namritha Ravinder2, David Kuninger1, Jasmeet Kaur1, Matthew A. Bailey1, Antje Taliana2, Mohan C. Vemuri3, Pauline T. Lieu1
1Primary and Stem Cell Systems, Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008, USA
2Molecular and Cell Biology, Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008, USA
3Primary and Stem Cell Systems, Life Technologies Corporation, 7335 Executive Way, Frederick, MD 21704, USA
Tóm tắt
The generation of induced pluripotent stem cells (iPSCs) from somatic cells has enabled the possibility of providing unprecedented access to patient-specific iPSC cells for drug screening, disease modeling, and cell therapy applications. However, a major obstacle to the use of iPSC for therapeutic applications is the potential of genomic modifications caused by insertion of viral transgenes in the cellular genome. A second concern is that reprogramming often requires the use of animal feeder layers and reagents that contain animal origin products, which hinder the generation of clinical-grade iPSCs. Here, we report the generation of iPSCs by an RNA Sendai virus vector that does not integrate into the cells genome, providing transgene-free iPSC line. In addition, reprogramming can be performed in feeder-free condition with StemPro hESC SFM medium and in xeno-free (XF) conditions. Generation of an integrant-free iPSCs generated in xeno-free media should facilitate the safe downstream applications of iPSC-based cell therapies.
Từ khóa
Tài liệu tham khảo
10.1016/j.cell.2006.07.024
10.1016/j.cell.2007.11.019
10.1038/nprot.2008.92
10.1126/science.1158799
10.1038/nature07677
10.1016/j.cell.2009.02.013
10.1038/nature05934
10.1038/nmeth.1591
10.1038/mt.2009.72
2012, Stem Cells and Development, 21, 530, 10.1089/scd.2011.0032
10.1016/j.stem.2008.11.012
10.1530/rep.1.01080
10.1128/JVI.74.14.6564-6569.2000
10.1006/exer.2002.1177
2001, The FASEB Journal, 15, 1294, 10.1096/fj.00-0460fje
